PHILADELPHIA, April 19, 2011 /PRNewswire/ -- Premier Research Group Limited announces the re-branding of its Medical Device business unit to D-TARGET, a Premier Research Company. With the continued growth in clinical development activity driven by rising regulatory and commercial demands in the medical device industry, Premier Research recognises this sector has specific needs.
D-TARGET was founded in 1997 and acquired by Premier Research in 2007. By reintroducing the name, Premier Research reinforces its focus on this sector and highlights the unique capability, expertise and experience gained by its staff operating as a dedicated Medical Device Contract Research Organization.
This division offers a team of medical device specialists with extensive experience in both the European Union and North America. D-TARGET's team of full time staff is located in more than 30 countries with primary offices in Yverdon, Switzerland and Boston, Massachusetts. Sponsors directly benefit from regional employees with their detailed knowledge of the local clinical research environment and ability to communicate with investigators and regulatory bodies in their own local language.
D-TARGET continues to offer a total life cycle partnership for developers of medical device and combination products, ranging from: strategic and tactical advisory services, clinical trial set-up and clinical trial operations through to post marketing surveillance and registry support. In conjunction with the clinical operational staff, D-TARGET has specialist support groups dedicated to: regulatory affairs, ethical committee, competent authority and country specific submissions, protocol writing, statistical analysis and data management, thereby enabling our teams to meet the full range of needs of medical device developers worldwide.
About Premier Research
Premier Research is a professional services company providing clinical development support to the pharmaceutical, biotechnology, and medical device industries. Founded in 1989 and headquartered in Philadelphia, USA, the company currently has 22 offices spread across Europe and North America and operates in over 30 countries worldwide. The company is a leader in performing clinical research in the analgesia, oncology, pediatrics, medical device and neurosciences areas. Additionally, it has grown a strong strategic sourcing group that supports customers in their resource planning and management.
The company offers a comprehensive series of services for every phase of clinical development including, regulatory affairs, clinical trial management, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, IVRS/IWRS, and quality assurance.
For more information please visit, www.premier-research.com.
SOURCE Premier Research Group Limited